government

FDA regulation of e-cigarettes rebuffed again

The agency has one more legal option -- the U.S. Supreme Court -- to prove why the popular products should face the same tests as medical devices.

By Alicia Gallegos — Posted Feb. 14, 2011

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Food and Drug Administration has lost another battle in its fight to regulate what goes into so-called electronic cigarettes.

The U.S. Court of Appeals for the District of Columbia Circuit on Jan. 24 said it would not review a decision blocking the products from FDA regulation as medical devices. An FDA spokesman said the agency is considering its legal and regulatory options. The FDA still could try to take the case to the U.S. Supreme Court.

An appellate panel of three judges in December 2010 said e-cigarettes did not meet the definition of medical devices under the Federal Food, Drug and Cosmetic Act. The classification would have required clinical trials for e-cigarettes.

Devices fall under that law only when marketed for therapeutic use, the judges said. E-cigarette manufacturers proved that their products are marketed for smoking pleasure and not cessation, according to the court.

The judges allowed the FDA jurisdiction over the products as "tobacco products," but that regulation includes less control and would take more time to implement.

"We were disappointed in the court's decision," said Tom Glynn, PhD, director of cancer science and trends at the American Cancer Society. "It really leaves e-cigarettes in a kind of netherworld."

E-cigarettes are battery-powered products designed to look like traditional cigarettes that allow users to inhale nicotine vapor without fire, smoke or ash. The product contains liquid nicotine, an ingredient derived from tobacco plants that has prompted safety concerns from public health organizations.

Studies show thousands of people use e-cigarettes daily, and the products generate an estimated $100 million annually in sales, Glynn said. Health advocates are not necessarily against the products as a whole, he said, but they want to make sure the ingredients are safe.

"What's the effect of putting that into your lungs?" he asked.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story